Streamlining Impurity Management Using LabSolutions Detect

Significance of the Topic

Automation of impurity detection and identification is critical in pharmaceutical development to ensure product safety, comply with regulatory impurity thresholds, and reliably monitor degradation products during stability testing. Manual review of multiple chromatograms risks missed peaks and human error; software-supported anomaly detection improves throughput, traceability, and consistency of impurity management workflows.

Study Objectives and Overview

This application note demonstrates how LabSolutions Detect—an anomaly peak detection support software—automates peak detection, identification and tracking across multiple samples and how coupling with a single-quadrupole mass spectrometer (LCMS-2050) provides complementary mass information for qualitative confirmation. The examples use one control and five model samples that simulate different impurity profiles composed of low-molecular-weight pharmaceuticals. Detection thresholds and automated workflows were applied to streamline impurity evaluation in line with regulatory expectations (ICH Q3A/Q3B).

Methodology

• Sample set: Control (no impurities) and five model mixtures spiked with representative pharmaceuticals to simulate impurity profiles.
• Automated criteria: Peak detection and tracking set to flag impurities with area percentage greater than 0.1% (upper limit for impurity reporting in this workflow).
• Data outputs: Automated entry of area percentages, color-coded visualization of flagged peaks, alignment of identical impurities across samples, and per-peak qualitative mass data from LCMS-2050.

Used Instrumentation

• UHPLC system: Nexera X3.
• Column: Shim-pack Scepter C18-120 (100 mm × 3.0 mm I.D., 1.9 µm).
• Mobile phase: 0.1% formic acid in water (A) and acetonitrile (B); gradient 5%→90% B from 0 to 5 min, re-equilibration 5–10 min.
• LC conditions: Column temperature 40 °C, flow 0.7 mL/min, injection 0.5 µL, UV detection at 254 nm (SPD-M40, STD cell).
• Mass spectrometer: LCMS-2050 single-quadrupole with DUIS ESI/APCI source; positive and negative ion modes; full scan m/z 80–1000.
• MS source parameters: Nebulizing gas 2.0 L/min, drying gas 5.0 L/min, heating gas 7.0 L/min, DL temp 200 °C, desolvation temp 450 °C, interface voltages +3.0 kV / -2.0 kV.

Main Results and Discussion

• Automated peak detection: LabSolutions Detect identified known components (Known 1–3) in the control and all samples and flagged multiple new impurities (New 1–New 5) in specific model samples according to the 0.1% area threshold.
• Peak tracking and alignment: Identical impurities across different samples were automatically grouped in the same output column, enabling immediate recognition that, for example, New 2 appeared in Samples 2, 3 and 4 while other New compounds were sample-specific.
• Visual outputs: Individual chromatograms highlighted detected impurities in red; a comparative view across all samples displayed impurity counts and retention time consistency for rapid review.
• Mass confirmation: LCMS-2050 provided qualitative m/z values for flagged peaks to aid identification. Representative observed ions reported in the examples included New 1 m/z 325 [M+H]+, New 2 m/z 189 [M+H]+, New 3 m/z 363 [M+H]+, New 4 m/z 329 [M-H]− and New 5 m/z 358 [M+H]+.
• Impact on QA workflows: Automated detection reduced the opportunity for overlooked peaks and inconsistent manual annotation, while mass data supported hypothesis generation for impurity structures prior to targeted confirmatory analyses.

Benefits and Practical Applications

• Efficiency: Automation shortens review time for batches of chromatograms and simplifies large-scale impurity surveillance (e.g., stability studies, synthetic route monitoring).
• Robustness: Consistent, rule-based detection minimizes operator-dependent variability and reduces the risk of missed low-level impurities near reporting thresholds.
• Traceability: Automatic recording of area percentages, retention times, and associated mass data facilitates audit trails and regulatory submissions.
• Pre-screening for follow-up: The coupling with a single-quadrupole MS provides quick qualitative evidence to prioritize peaks for higher-resolution MS/MS or reference standard confirmation.

Future Trends and Potential Uses

• Integration with high-resolution mass spectrometry and MS/MS libraries to move from qualitative m/z assignment to structural elucidation and automated tentative ID.
• Machine learning enhancements for smarter anomaly scoring, deconvolution of coeluting peaks, and predictive impurity annotation across process development datasets.
• Stronger connectivity with LIMS and automated reporting pipelines to accelerate regulatory documentation and batch release decisions.
• Expansion of automated workflows to full stability programs, impurity profiling during synthetic route scouting, and forced-degradation studies.
• Regulatory harmonization and validation packages tailored to automated impurity-detection software to increase confidence for routine QA/QC use.

Conclusion

Automated anomaly peak detection using LabSolutions Detect, combined with single-quadrupole mass data from the LCMS-2050, streamlines impurity management by improving detection consistency, reducing manual review burden, and providing qualitative mass information for flagged peaks. This approach supports regulatory-compliant impurity surveillance (ICH Q3A/Q3B), accelerates decision-making in development and stability testing, and forms a foundation for deeper integration with advanced MS and informatics tools for future analytical workflows.

References

1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Q3A and Q3B Impurities guidance documents.
2. Shimadzu Corporation. Application note: Streamlining Impurity Management Using LabSolutions Detect. First Edition: Jun. 2026.